Not an SEC registrant

Optum Frontier Therapies LLC

Customers

None disclosed

Suppliers

1 disclosed

Latest period

Dec 31, 2024

10-K filed 2025-03-03

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Suppliers 1

Companies that disclose Optum Frontier Therapies LLC as a major customer, as a share of their own revenue. 1 active, 0 lapsed.

Company	% of their revenue	Est. $ from Optum Frontier Therapies LLC	Period	Trend	Status	Source
AVADEL PHARMACEUTICALS PLC AVADEL PHARMACEUTICALS PLC	Named	—	FY 2024-12-31	—	Active	10-K 2025-03-03
Accredo Health Group, Inc. (“Accredo”), which accounted for 25% of gross accounts receivable; and Optum Frontier Therapies LLC (“Optum”), which accounted for 22% of gross accounts receivable. 10-K filed 2025-03-03 Period FY 2024-01-01 to 2024-12-31Accession 0001012477-25-000010 Accredo Health Group, Inc. (“Accredo”), which accounted for 28% of gross accounts receivable; and Optum Frontier Therapies LLC (“Optum”), which accounted for 20% of gross accounts receivable. 10-K filed 2024-02-29 Period FY 2023-01-01 to 2023-12-31Accession 0001012477-24-000008

Alerts are coming

Get an email when Optum Frontier Therapies LLC's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.